Download PDF
Synlett 2002(2): 0219-0222
DOI: 10.1055/s-2002-19754
LETTER
© Georg Thieme Verlag Stuttgart · New York

The Synthesis of a Novel Carbazole-linked Cyclic Peptoid with Antibacterial Activity

John B. Bremner*a, Jonathan A. Coatesb, Paul A. Keller*a, Stephen G. Pyne*a, Helen M. Witcharda
a Department of Chemistry, University of Wollongong, Wollongong, NSW, 2522, Australia
b AMRAD Corporation Ltd, Richmond, Victoria, 3121, Australia
Fax: +61(2)42214287; e-Mail: john_bremner@uow.edu.au; e-Mail: paul_keller@uow.edu.au; e-Mail: stephen_pyne@uow.edu.au;
Further Information

Publication History

Received 30 October 2001
Publication Date:
02 February 2007 (online)

    Permissions and Reprints All articles of this category

Abstract

This paper describes the synthesis of a novel cyclic peptoid 11, structurally comprising a tripeptide moiety linked through a carbazole scaffold. In a key step, a ring-closing metathesis reaction was used giving efficient access to a new class of cyclic peptoids.

Key words

cyclic peptoid - ring-closing metathesis - antibacterial activity

    References

  • 1 Uttley AHC. Collins CH. Naidoo J. George RC. Lancet  1988,  1:  57 
    Google Scholar
  • 2a Pegues DA. Pegues CF. Hibberd PL. Ford DS. Hooper DC. J. Clin. Microbiol.  1997,  35:  1565 
    Google Scholar
  • 2b Elsner HA. Sobottka I. Feucht HH. Harps E. Haun C. Mack D. Ganschow R. Laufs R. Kaulfers PM. Int. J. Hyg. Environ. Health  2000,  203:  147 
    Google Scholar
  • 3a Ariza J. Pujol M. Cabo J. Pena C. Fernandez N. Linares J. Ayats J. Gudiol F. Lancet  1999,  353:  1587 
    Google Scholar
  • 3b Smith TL. Pearson ML. Wilcox KR. Cruz C. Lancaster MV. Robinson-Dunn B. Tenover FC. Zervos MJ. Band JD. White E. Jarvis WR. N. Eng. J. Med.  1999,  340:  493 
    Google Scholar
  • 4 Noskin GA. Siddiqui F. Stosor V. Kruzynski J. Peterson LR. Clin. Infect. Dis.  1999,  28:  689 
    Google Scholar
  • 5 Tsiodras S. Gold HS. Sakoulas G. Eliopoulos GM. Wennersten C. Venkataraman L. Moellering RC. Ferraro MJ. Lancet  2001,  358:  207 
    Google Scholar
  • 6 Gonzales RD. Schreckenberger PC. Graham MB. Kelkar S. DenBesten K. Quinn JP. Lancet  2001,  357:  1179 
    CrossrefGoogle Scholar
  • 7 Arthur M. Courvalin P. Antimicrob. Agents Chemother.  1993,  37:  1563 
    Google Scholar
  • 8 Williams DH. Bardsley B. Angew. Chem. Int. Ed.  1999,  38:  1172 
    CrossrefPubMedGoogle Scholar
  • 9a Nicolaou KC. Mitchell HJ. Jain NF. Winssinger N. Hughes R. Bando T. Angew. Chem. Int. Ed.  1999,  38:  240 
    CrossrefGoogle Scholar
  • 9b Nicolaou KC. Mitchell HJ. Jain NF. Bando T. Hughes R. Winssinger N. Natarajan S. Koumbis AE. Chem.-Eur. J.  1999,  5:  2648 
    CrossrefGoogle Scholar
  • 9c For the synthesis of vancomycin aglycone see: Boger DL. Miyazaki S. Kim SH. Wu JH. Castle SL. Loiseleur O. Jin Q. J. Am. Chem. Soc.  1999,  121:  10004 
    CrossrefGoogle Scholar
  • 9d See also: Evans DA. Wood MR. Trotter BW. Richardson TI. Barrow JC. Katz JL. Angew. Chem. Int. Ed.  1998,  37:  2700 
    CrossrefGoogle Scholar
  • 9e See also: Nicolaou KC. Takayanagi M. Jain NF. Natarajan S. Koumbis AE. Bando T. Ramanjulu JM. Angew. Chem. Int. Ed.  1998,  37:  2717 
    CrossrefGoogle Scholar
  • 9f For the synthesis of vancomycin from its aglycone see: Thompson C. Ge M. Kahne D. J. Am. Chem. Soc.  1999,  121:  1237 
    CrossrefGoogle Scholar
  • 10 Malabarba A. Nicas TI. Thompson RC. Med. Res. Rev.  1997,  17:  69 
    CrossrefGoogle Scholar
  • 11 Rao AVR. Gurjar MK. Reddy KL. Rao AS. Chem. Rev.  1995,  95:  2135 
    CrossrefGoogle Scholar
  • 12 Kaplan J. Korty BD. Axelsen PH. Loll PJ. J. Med. Chem.  2001,  44:  1837 
    CrossrefGoogle Scholar
  • 14 Yamamoto H. J. Org. Chem.  1967,  32:  3693 
    Google Scholar
  • 15 Hayakawa K. Yasukouchi T. Kanematsu K. Tetrahedron Lett.  1986,  27:  1837 
    CrossrefGoogle Scholar
  • 16 Lygo B. Tetrahedron Lett.  1999,  40:  1389 
    CrossrefGoogle Scholar
  • 17 Lenna MR. Morton HE. Tetrahedron Lett.  1993,  34:  4485 
    CrossrefGoogle Scholar
  • 18 Krapcho AP. Weimaster JF. J. Org. Chem.  1980,  45:  4105 
    Google Scholar
  • 19 Cummins CH. Tetrahedron Lett.  1994,  35:  857 
    CrossrefGoogle Scholar
  • 20 Corey EJ. Narasaka K. Shibasaki M. J. Am. Chem. Soc.  1976,  98:  6417 
    CrossrefGoogle Scholar
  • 21a Schwab P. Grubbs RH. Ziller JW. J. Am. Chem. Soc.  1996,  118:  100 
    CrossrefGoogle Scholar
  • 21b For examples of ring-closing metathesis of peptoid-based systems with newer generation catalysts, see: Blackwell HE. Sadowsky JD. Howard RJ. Sampson JN. Chao JA. Steinmetz WE. O’Leary DJ. Grubbs RH. J. Org. Chem.  2001,  66:  5291 
    CrossrefGoogle Scholar
  • 22 For a review of Grubbs’ metathesis reactions, see: Schuster M. Blechert S. Angew. Chem., Int. Ed. Engl.  1997,  36:  2036 
    CrossrefGoogle Scholar
13

Physical properties, 1H NMR and microanalytical/HRMS data for compounds in the Scheme were as follows:
1: Mp 108-110 °C. 1H NMR (400 MHz, C6D6): δ = 7.78 (d, J = 2.0 Hz, 1 H, ArH-5), 7.41 (dd, J = 8.4, 2.0 Hz, 1 H, ArH-7), 6.77 (d, J = 8.4 Hz, 1 H, ArH-8), 6.23 (br s, 1 H, NH), 2.53 (dd, J = 15.0, 5.2 Hz, 1 H, H-4), 2.32-2.15 (m, 2 H, H-1 and H-2), 2.01 (dd, J = 15.2, 9.4 Hz, 1 H, H-4), 1.73-1.61 (m, 2 H, H-2 and H-3), 1.29 (m, 1 H, H-1), 0.99 (d, J = 6.8 Hz, 3 H, CH3). HRMS (CI+) calcd for C13H14 79BrN + H: 264.0388; found: 264.0371. Anal. Calcd for C13H14BrN: C, 59.11; H, 5.34; N, 5.30. Found: C, 59.33; H, 5.38; N, 5.26.
2: Mp 120-122 °C. 1H NMR (300 MHz, C6D6): δ = 8.27 (d, J = 8.7 Hz, 1 H, ArH-8), 7.61 (d, J = 2.1 Hz, 1 H, ArH-5), 7.44 (dd, J = 8.7, 2.1 Hz, 1 H, ArH-7), 3.06-2.94 (m, 1 H, H-1), 2.85-2.70 (m, 1 H, H-2), 2.36 (dd, J = 16.0, 5.4 Hz, 1 H, H-4), 1.90-1.78 (m, 1 H, H-4), 1.65 (m, 2 H, H-2 and H-3), 1.38 (s, 9 H, C(CH3)3), 1.30-1.16 (m, 1 H, H-1), 0.96 (d, J = 6.6 Hz, 3 H, CHCH3). HRMS (EI+) calcd for C18H22 79BrNO2: 363.0834; found: 363.0832. Anal. Calcd for C18H22BrNO2: C, 59.35; H, 6.09; N, 3.85; O, 8.78. Found: C, 59.50; H, 6.20; N, 3.79; O, 8.81.
3: Mp 94-96 °C. 1H NMR (300 MHz, CDCl3): δ = 8.14 (d, J = 9.0 Hz, 1 H, ArH-1), 8.10 (d, J = 8.7 Hz, 1 H, ArH-8), 7.99 (d, J = 2.1 Hz, 1 H, ArH-4), 7.65 (br s, 1 H, ArH-5), 7.50 (dd, J = 8.9, 2.1 Hz, 1 H, ArH-2), 7.27 (dd, J = 8.4, 1.8 Hz, 1 H, ArH-7), 2.48 (s, 3 H, ArCH3), 1.74 (s, 9 H, C(CH3)3). HRMS (CI+) calcd for C18H18 79BrNO2 + H: 360.0599; found: 360.0600. Anal. Calcd for C18H18BrNO2: C, 60.01; H, 5.04; N, 3.89; O, 8.88. Found: C, 59.89; H, 5.05; N, 3.86; O, 8.95.
4: Mp 150 °C(dec). 1H NMR (400 MHz, CDCl3): δ = 8.22 (d, J = 8.4 Hz, 1 H, ArH-8), 8.16 (d, J = 8.8 Hz, 1 H, ArH-1), 8.07 (d, J = 2.0 Hz, 1 H, ArH-4), 7.93 (d, J = 1.6 Hz, 1 H, ArH-5), 7.54 (dd, J = 8.8, 2.0 Hz, 1 H, ArH-2), 7.50 (dd, J = 8.8, 2.0 Hz, 1 H, ArH-7), 4.66 (s, 2 H, CH2), 1.73 (s, 9 H, CH3). HRMS (EI+) calcd for C18H17 79Br2NO2: 436.9626; found: 436.9670. Anal. Calcd for C18H17Br2NO2: C, 49.23; H, 3.90; N, 3.19; O, 7.29. Found: C, 49.30; H, 3.86; N, 3.11; O, 6.91.
5: Mp 173-175 °C. 1H NMR (300 MHz, CDCl3): δ = 8.49 (s, 1 H, ArNH), 8.05 (d, J = 1.8 Hz, 1 H, ArH-5), 7.69 (br s, 1 H, ArH-4), 7.43 (dd, J = 8.6, 1.8 Hz, 1 H, ArH-7), 7.25 (d, J = 9.0 Hz, 1 H, ArH-1), 7.23 (d, J = 8.4 Hz, 1 H, ArH-8), 7.12 (dd, J = 8.3, 1.5 Hz, 1 H, ArH-2), 6.05 (d, J = 7.5 Hz, 1 H, NH), 4.90 (dt, J = 7.8, 6.0 Hz, 1 H, CHN), 4.16 (q, J = 7.2 Hz, 2 H, OCH 2CH3) 3.27 (dd, J = 14.1, 6.3 Hz, 1 H, ArCH2), 3.20 (dd, J = 14.0, 5.9 Hz, 1 H, ArCH2), 1.96 (s, 3 H, COCH3), 1.22 (t, J = 7.2 Hz, 3 H, OCH2CH 3). HRMS (CI+) calcd for C19H19 79BrN2O3 + H: 403.0657; found: 403.0664.
6: Mp 98-100 °C. 1H NMR (300 MHz, CDCl3): δ = 8.13 (br s, 1 H, ArNH) 7.80 (br s, 1 H, ArH-5), 7.76 (br s, 1 H, ArH-4), 7.32 (d, J = 8.7 Hz, 1 H, ArH-8), 7.29 (d, J = 8.4 Hz, 1 H, ArH-1), 7.22 (dd, J = 8.7, 1.2 Hz, 1 H, ArH-7), 7.10 (dd, J = 8.4, 1.5 Hz, 1 H, ArH-2), 6.05 (ddt, J = 16.8, 10.2, 6.6 Hz, 1 H, CH2CH=CH2), 5.96 (d, J = 8.4 Hz, 1 H, NH), 5.11 (dd, J = 17.4, 1.8 Hz, 1 H, CH2CH=CH 2), 5.08 (dd, J = 9.3, 2.1 Hz, 1 H, CH2CH=CH 2), 4.90 (dt, J = 7.8, 6.3 Hz, 1 H, CHN), 4.17 (q, J = 7.2 Hz, 2 H, OCH 2CH3), 3.54 (d, J = 6.6 Hz, 2 H, CH 2CH=CH2), 3.26 (d, J = 5.7 Hz, 2 H, ArCH2), 1.97 (s, 3 H, COCH 3), 1.23 (t, J = 7.2 Hz, 3 H, OCH2CH3). HRMS (CI+) calcd for C22H24N2O3 + H: 365.1865; found: 365.1859.
7: Mp 123-125 °C. 1H NMR (300 MHz, CDCl3): δ = 8.18 (d, J = 8.1 Hz, 1 H, ArH-8), 8.16 (d, J = 8.1 Hz, 1 H, ArH-1), 7.71 (d, J = 1.2 Hz, 1 H, ArH-4), 7.68 (d, J = 1.5 Hz, 1 H, ArH-5), 7.27 (dd, J = 8.5, 1.5 Hz, 1 H, ArH-2), 7.17 (dd, J = 8.5, 1.8 Hz, 1 H, ArH-7), 6.03 (ddt, J = 16.5, 9.9, 6.9 Hz, 1 H, CH2CH=CH2), 5.11 (dd, J = 17.7, 1.8 Hz, 1 H, CH2CH=CH 2), 5.10 (dd, J = 10.2, 1.8 Hz, 1 H, CH2CH=CH 2), 4.90 (dt, J = 7.5, 6.0 Hz, 1 H, CHN), 4.17 (q, J = 7.2 Hz, 2 H, OCH 2CH3), 3.52 (d, J = 6.6 Hz, 2 H, CH 2CH=CH2), 3.28 (dd, J = 14.0, 5.7 Hz, 1 H, ArCH2), 3.22 (dd, J = 14.1, 5.7 Hz, 1 H, ArCH2), 1.98 (s, 3 H, COCH3), 1.72 (s, 9 H, C(CH3)3), 1.23 (t, J = 7.2 Hz, 3 H, OCH2CH3). HRMS (ES+) calcd for C27H32N2O5 + H: 465.2389; found: 465.2408. Anal. Calcd for C27H32N2O5: C, 69.80; H, 6.94; N, 6.03; O, 17.22. Found: C, 69.87; H, 7.14; N, 5.88; O, 17.11.
8: Mp 175-177 °C. 1H NMR (300 MHz, (CD3)2CO): δ = 8.21 (d, J = 8.4 Hz, 1 H, ArH-8); 8.20 (d, J = 8.7 Hz, 1 H, ArH-1), 7.96 (d, J = 1.2 Hz, 1 H, ArH-4), 7.89 (d, J = 0.9 Hz, 1 H, ArH-5), 7.39 (dd, J = 8.4, 1.5 Hz, 2 H, ArH-2 and CHN(obscured)), 7.33 (dd, J = 8.5, 1.8 Hz, 1 H, ArH-7), 6.07 (ddt, J = 16.9, 9.9, 6.9 Hz, 1 H, CH2CH=CH2), 5.14 (dd, J = 17.2, 1.5 Hz, 1 H, CH2CH=CH 2), 5.07 (dd, J = 9.9, 1.5 Hz, 1 H, CH2CH=CH 2), 4.80 (m, 1 H, CHN), 3.55 (d, J = 6.9 Hz, 2 H, CH 2CH=CH2), 3.34 (dd, J = 13.8, 5.4 Hz, 1 H, ArCH2), 3.15 (dd, J = 13.8, 8.1 Hz, 1 H, ArCH2), 1.89 (s, 3 H, COCH3), 1.76 (s, 9 H, C(CH3)3). HRMS (ES+) calcd for C25H28N2O5 + H: 437.2076; found: 437.2072. Anal. Calcd for C25H28N2O5: C, 68.79; H, 6.47; N, 6.42; O, 18.33. Found: C, 68.90; H, 6.69; N, 6.34; O, 18.07.
9: Mp 156-158 °C. 1H NMR (500 MHz, CDCl3, * indicates signals for minor isomer): δ = 8.16 (d, J = 7.5 Hz, 0.7 H, ArH-1), 8.14* (d, J = 7.5 Hz, 0.3 H, ArH-1), 8.10 (d, J = 8.0 Hz, 0.7 H, ArH-8), 8.08* (d, J = 8.0 Hz, 0.3 H, ArH-8), 7.74 (s, 1 H, ArH-4), 7.70 (d, J = 7.5 Hz, 1.3 H, Fmoc ArH-4 and Fmoc ArH-5), 7.69* (d, J = 7.5 Hz, 0.7 H, Fmoc ArH-4 and Fmoc ArH-5), 7.64* (s, 0.3 H, ArH-5), 7.60 (s, 0.7 H, ArH-5), 7.54 (d, J = 7.5 Hz, 1.3 H, Fmoc ArH-1 and Fmoc ArH-8), 7.51* (d, J = 7.5 Hz, 0.7 H, Fmoc ArH-1 and Fmoc ArH-8), 7.40-7.35* (m, 0.3 H, NH-6), 7.34 (t, J = 7.5 Hz, 2 H, Fmoc ArH-3 and Fmoc ArH-6), 7.29-7.18 (m, 4 H, Fmoc ArH-2, Fmoc ArH-7, ArH-2 and ArH-7), 7.15* (d, J = 7.0 Hz, 0.3 H, NH-3), 7.11 (d, J = 7.5 Hz, 0.7 H, NH-3), 7.05 (d, J = 7.5 Hz, 0.7 H, NH-6), 6.89* (d, J = 7.5 Hz, 0.3 H, NHAc), 6.81 (d, J = 7.5 Hz, 0.7 H, NHAc), 5.98 (m, 1 H, ArCH2CH=CH2), 5.61 (m, 1 H, CH2CH=CH2), 5.41* (br s, 1 H, NH-5), 5.12-4.98 (m, 5 H, NH-5, ArCH2CH=CH 2 and CH2CH=CH 2), 4.93* (br d, J = 7.0 Hz, 0.3 H, CHN-8), 4.86 (dt, J = 7.5, 7.0 Hz, 0.7 H, CHN-8), 4.59* (br d, J = 6.5 Hz, 0.3 H, CHN-5), 4.52 (br d, J = 6.0 Hz, 0.7 H, CHN-2), 4.51-4.41 (m, 1 H, CHN-5 and CHN-2*), 4.32 (d, J = 7.0 Hz, 2 H, OCH2), 4.13 (t, J = 6.5 Hz, 1 H, Fmoc CH), 3.64* (s, 1 H, OCH3), 3.62 (s, 2 H, OCH3), 3.45* (d, J = 5.5 Hz, 0.7 H, ArCH 2CH=CH2), 3.44 (d, J = 6.5 Hz, 1.3 H, ArCH 2CH=CH2), 3.24-3.12 (m, 2 H, ArCH2-9), 3.08* (br d, J = 6.0 Hz, 0.7 H, NCH 2(CH2)3), 2.94-2.77 (m, 1.3 H, NCH 2(CH2)3), 2.53-2.31 (m, 2 H, CH 2CH=CH2), 1.93 (s, 2 H, COCH3), 1.92* (s, 1 H, COCH3), 1.84-1.55* (m, 0.7 H, N(CH2)3CH 2), 1.60-1.49 (m, 0.65 H, N(CH2)3CH 2), 1.46-1.26 (m, 2.05 H, N(CH2)3CH 2, N(CH2)2CH 2CH2 * and NCH2CH 2(CH2)2 *), 1.22-1.06 (m, 1.3 H, NCH2CH 2(CH2)2), 1.04-0.89 (m, 1.3 H, N(CH2)2CH 2CH2). HRMS (ES+) calcd for C52H59N5O9 + H: 898.4391; found: 898.4359. Anal. Calcd for C52H59N5O9: C, 69.55; H, 6.62; N, 7.80; O, 16.03. Found: C, 69.71; H, 6.78; N, 7.67; O, 15.84.
10: Mp 189-191 °C. HRMS (ES+) calcd for C50H55N5O9 + H: 870.4099; found: 870.4078.
11: Mp 230 °C(dec). HRMS (ES+) calcd for C35H45N5O7 + H: 648.3397; found: 648.3391.